UBS Group’s CNS Pharmaceuticals CNSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5K | Buy |
32,103
+8,125
| +34% | +$6.7K | ﹤0.01% | 6948 |
|
|
2025
Q1 | $32.6K | Sell |
23,978
-40,440
| -63% | -$55K | ﹤0.01% | 6590 |
|
|
2024
Q4 | $7.73K | Sell |
64,418
-117,448
| -65% | -$14.1K | ﹤0.01% | 7219 |
|
|
2024
Q3 | $23.8K | Buy |
181,866
+179,237
| +6,818% | +$23.5K | ﹤0.01% | 6061 |
|
|
2024
Q2 | $4.15K | Buy |
+2,629
| New | +$4.15K | ﹤0.01% | 6966 |
|
|
2023
Q4 | – | Sell |
-55
| Closed | -$63 | – | 8127 |
|
|
2023
Q3 | $63 | Sell |
55
-1,071
| -95% | -$1.23K | ﹤0.01% | 7824 |
|
|
2023
Q2 | $2.51K | Sell |
1,126
-1,331
| -54% | -$2.97K | ﹤0.01% | 6659 |
|
|
2023
Q1 | $2.46K | Buy |
2,457
+1,244
| +103% | +$1.24K | ﹤0.01% | 7410 |
|
|
2022
Q4 | $2.91K | Buy |
+1,213
| New | +$2.91K | ﹤0.01% | 8404 |
|
|
2022
Q1 | – | Sell |
-3,653
| Closed | -$3K | – | 9207 |
|
|
2021
Q4 | $3K | Buy |
+3,653
| New | +$3K | ﹤0.01% | 8523 |
|
|
2021
Q3 | – | Sell |
-4,676
| Closed | -$9K | – | 8402 |
|
|
2021
Q2 | $9K | Buy |
4,676
+3,316
| +244% | +$6.38K | ﹤0.01% | 7025 |
|
|
2021
Q1 | $3K | Buy |
+1,360
| New | +$3K | ﹤0.01% | 7464 |
|
|
2020
Q4 | – | Sell |
-3,960
| Closed | -$7K | – | 7372 |
|
|
2020
Q3 | $7K | Buy |
+3,960
| New | +$7K | ﹤0.01% | 6220 |
|
|
2020
Q2 | – | Sell |
-1,930
| Closed | -$4K | – | 7078 |
|
|
2020
Q1 | $4K | Buy |
+1,930
| New | +$4K | ﹤0.01% | 6452 |
|